Novo CEO pressed by Senate to cut charges of obesity, diabetes drugs CEO Lars Fruergaard Jørgensen advised lawmakers the business would take into consideration new talks with insurers with regard to the list price ranges of Wegovy and copyright whenever they pledge to help keep the medicines on their own https://milogouah.tkzblog.com/30536855/everything-about-healthcare-news